Meeting Background

This is a public workshop sponsored by FDA’s Office of New Drugs. It is aimed to bring experts in the area of neurotoxicity biomarkers from academia and industry to get their perspective on the need of circulating and MR imaging biomarkers of CNS damage for their utility in preclinical toxicity studies.

Attending a Public Meeting

Onsite registration and check-in will begin at 7:30am EST on July 23, 2019. Please register by 11:59 pm on Eventbrite at July 21, 2019.

Visiting FDA

Entrance for the public meeting participants (non-FDA employees) is through Building 1. Please allow time for routine security checks, as procedures will be performed. For parking and security information, please refer to https://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/ucm241740.htm.

Special Accommodations

If you need special accommodations due to a disability, please contact Tiara Watkins, Tiara.Watkins@fda.hhs.gov, no later than July 12, 2019, at 4:00 pm. Eastern Time.

Webcast Information

This public meeting will be available for online viewing, on the day of the meeting, click on the link to attend: https://collaboration.fda.gov/bioneuro/

If you have never attended a Connect Pro event before, test your connection at https://collaboration.fda.gov/common/help/en/support/meeting_test.htm. To get a quick overview of the Connect Pro program, visit https://www.adobe.com/go/connectpro_overview.

Meeting Materials (Agenda, etc.)

Will be uploaded to the public FDA website at a later date.